Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Report 2023

Global CRISPR and CRISPR-Associated (Cas) Genes Sales Market Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2018-2029)
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2018-2023)
2.4 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
2.5.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
2.5.3 China CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
2.5.4 Japan CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
2.5.5 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
2.5.6 India CRISPR and CRISPR-Associated (Cas) Genes Estimates and Projections (2018-2029)
3 Global CRISPR and CRISPR-Associated (Cas) Genes Competition Landscape by Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2018-2023)
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2018-2023)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2018-2023)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2022
3.5 CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Area Served
3.6 Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
3.7 Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2018-2023)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2024-2029)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2018-2023)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2024-2029)
6 United States CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
6.1 United States CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
6.2 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
6.2.1 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
6.2.2 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
6.2.3 United States CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
6.3 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
6.3.1 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
6.3.2 United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
6.3.3 United States CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
7 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
7.2.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
7.2.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
7.2.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
7.3.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
7.3.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
7.3.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
8 China CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
8.1 China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
8.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
8.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
8.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
8.2.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
8.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
8.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
8.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
8.3.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
9 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
9.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
9.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
9.2.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
9.2.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
9.2.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
9.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
9.3.1 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
9.3.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
9.3.3 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
10 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
10.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
10.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
10.2.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
10.2.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
10.2.3 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
10.3 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
10.3.1 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
10.3.2 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
10.3.3 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
11 India CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures
11.1 India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023)
11.2 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
11.2.1 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)
11.2.2 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)
11.2.3 India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
11.3 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
11.3.1 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)
11.3.2 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)
11.3.3 India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Company Details
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Editas Medicine
12.2.1 Editas Medicine Company Details
12.2.2 Editas Medicine Business Overview
12.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.2.5 Editas Medicine Recent Development
12.3 Caribou Biosciences
12.3.1 Caribou Biosciences Company Details
12.3.2 Caribou Biosciences Business Overview
12.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.3.5 Caribou Biosciences Recent Development
12.4 CRISPR therapeutics
12.4.1 CRISPR therapeutics Company Details
12.4.2 CRISPR therapeutics Business Overview
12.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.4.5 CRISPR therapeutics Recent Development
12.5 Intellia therapeutics, Inc.
12.5.1 Intellia therapeutics, Inc. Company Details
12.5.2 Intellia therapeutics, Inc. Business Overview
12.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.5.5 Intellia therapeutics, Inc. Recent Development
12.6 Cellectis
12.6.1 Cellectis Company Details
12.6.2 Cellectis Business Overview
12.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.6.5 Cellectis Recent Development
12.7 Horizon Discovery Plc
12.7.1 Horizon Discovery Plc Company Details
12.7.2 Horizon Discovery Plc Business Overview
12.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.7.5 Horizon Discovery Plc Recent Development
12.8 Sigma Aldrich
12.8.1 Sigma Aldrich Company Details
12.8.2 Sigma Aldrich Business Overview
12.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.8.5 Sigma Aldrich Recent Development
12.9 Precision Biosciences
12.9.1 Precision Biosciences Company Details
12.9.2 Precision Biosciences Business Overview
12.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.9.5 Precision Biosciences Recent Development
12.10 Genscript
12.10.1 Genscript Company Details
12.10.2 Genscript Business Overview
12.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.10.5 Genscript Recent Development
12.11 Sangamo Biosciences Inc.
12.11.1 Sangamo Biosciences Inc. Company Details
12.11.2 Sangamo Biosciences Inc. Business Overview
12.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.11.5 Sangamo Biosciences Inc. Recent Development
12.12 Lonza Group Limited
12.12.1 Lonza Group Limited Company Details
12.12.2 Lonza Group Limited Business Overview
12.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.12.5 Lonza Group Limited Recent Development
12.13 Integrated DNA Technologies
12.13.1 Integrated DNA Technologies Company Details
12.13.2 Integrated DNA Technologies Business Overview
12.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.13.5 Integrated DNA Technologies Recent Development
12.14 New England Biolabs
12.14.1 New England Biolabs Company Details
12.14.2 New England Biolabs Business Overview
12.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.14.5 New England Biolabs Recent Development
12.15 Origene Technologies
12.15.1 Origene Technologies Company Details
12.15.2 Origene Technologies Business Overview
12.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
12.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
12.15.5 Origene Technologies Recent Development
13 Market Dynamics
13.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
13.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
13.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
13.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Market Share by Region (2018-2023))
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Region (2018-2023)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) Forecast by Region (2024-2029)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share Forecast by Region (2024-2029)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players (2018-2023)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2022)
Table 18. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players CRISPR and CRISPR-Associated (Cas) Genes Product Solution and Service
Table 22. Date of Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2018-2023)
Table 26. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2024-2029)
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2018-2023)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2024-2029)
Table 32. United States CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 33. United States CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 34. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (K Units)
Table 35. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (K Units)
Table 36. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (K Units)
Table 37. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (K Units)
Table 38. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)
Table 44. China CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 45. China CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 46. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 47. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)
Table 48. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 49. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)
Table 50. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 51. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 52. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 53. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)
Table 54. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 55. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)
Table 56. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 57. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 58. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 59. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)
Table 60. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 61. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)
Table 62. India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2018-2023) & (US$ Million)
Table 63. India CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2023)
Table 64. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)
Table 65. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)
Table 66. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)
Table 67. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Description and Business Overview
Table 70. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 71. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Editas Medicine Company Details
Table 74. Editas Medicine Description and Business Overview
Table 75. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 76. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 77. Editas Medicine Recent Development
Table 78. Caribou Biosciences Company Details
Table 79. Caribou Biosciences Description and Business Overview
Table 80. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 81. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 82. Caribou Biosciences Recent Development
Table 83. CRISPR therapeutics Company Details
Table 84. CRISPR therapeutics Description and Business Overview
Table 85. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 86. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 87. CRISPR therapeutics Recent Development
Table 88. Intellia therapeutics, Inc. Company Details
Table 89. Intellia therapeutics, Inc. Description and Business Overview
Table 90. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 91. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 92. Intellia therapeutics, Inc. Recent Development
Table 93. Cellectis Company Details
Table 94. Cellectis Description and Business Overview
Table 95. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 96. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 97. Cellectis Recent Development
Table 98. Horizon Discovery Plc Company Details
Table 99. Horizon Discovery Plc Description and Business Overview
Table 100. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 101. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 102. Horizon Discovery Plc Recent Development
Table 103. Sigma Aldrich Company Details
Table 104. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 105. Sigma Aldrich Description and Business Overview
Table 106. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 107. Sigma Aldrich Recent Development
Table 108. Precision Biosciences Company Details
Table 109. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 110. Precision Biosciences Description and Business Overview
Table 111. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 112. Precision Biosciences Recent Development
Table 113. Genscript Company Details
Table 114. Genscript Description and Business Overview
Table 115. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 116. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 117. Genscript Recent Development
Table 118. Sangamo Biosciences Inc. Company Details
Table 119. Sangamo Biosciences Inc. Description and Business Overview
Table 120. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 121. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 122. Sangamo Biosciences Inc. Recent Development
Table 123. Lonza Group Limited Company Details
Table 124. Lonza Group Limited Description and Business Overview
Table 125. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 126. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 127. Lonza Group Limited Recent Development
Table 128. Integrated DNA Technologies Company Details
Table 129. Integrated DNA Technologies Description and Business Overview
Table 130. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 131. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 132. Integrated DNA Technologies Recent Development
Table 133. New England Biolabs Company Details
Table 134. New England Biolabs Description and Business Overview
Table 135. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 136. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 137. New England Biolabs Recent Development
Table 138. Origene Technologies Company Details
Table 139. Origene Technologies Description and Business Overview
Table 140. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 141. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)
Table 142. Origene Technologies Recent Development
Table 143. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 144. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 145. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 146. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2022 VS 2029
Figure 2. Genome Editing Features
Figure 3. Genetic engineering Features
Figure 4. gRNA Database/Gene Librar Features
Figure 5. CRISPR Plasmid Features
Figure 6. Human Stem Cells Features
Figure 7. Genetically Modified Organisms/Crops Features
Figure 8. Cell Line Engineering Features
Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2022 VS 2029
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region: 2018 VS 2022
Figure 18. United States CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 19. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 20. China CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 21. Japan CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 22. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 23. India CRISPR and CRISPR-Associated (Cas) Genes Revenue (Million USD) Growth Rate (2018-2029)
Figure 24. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2022
Figure 25. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2022)
Figure 26. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2022
Figure 27. United States CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 28. United States CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 30. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 31. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 32. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 33. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 34. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 35. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 36. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 37. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)
Figure 38. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)
Figure 39. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)
Figure 40. Editas Medicine Revenue Growth Rate in CRISPR and

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Sanger Sequencing Service Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149

According to our LPI (LP Information) latest study, the global Sanger Sequencing Service market size was valued at US$ 209 million in 2023. With growing demand in downstream market, the Sanger Sequencing Service is forecast to a readjusted size of US$ 206.7 million by 2030 with a CAGR of -0.2% during review period. The research report highlights the growth potential of the global Sanger Sequencing Service market. Sanger Sequencing Service are expected to show stable growth in the future ......

Global Whole Exome Sequencing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Whole Exome Sequencing market size was valued at US$ 289.6 million in 2023. With growing demand in downstream market, the Whole Exome Sequencing is forecast to a readjusted size of US$ 633.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential of the global Whole Exome Sequencing market. Whole Exome Sequencing are expected to show stable growth in the future market. Ho......

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 154

According to our LPI (LP Information) latest study, the global Single Nucleotide Polymorphism (SNP) Genotyping market size was valued at US$ 16530 million in 2023. With growing demand in downstream market, the Single Nucleotide Polymorphism (SNP) Genotyping is forecast to a readjusted size of US$ 66080 million by 2030 with a CAGR of 21.9% during review period. The research report highlights the growth potential of the global Single Nucleotide Polymorphism (SNP) Genotyping market. Single ......

Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR and CRISPR-Associated (Cas) Genes is forecast to a readjusted size of US$ 10020 million by 2030 with a CAGR of 33.1% during review period. The research report highlights the growth potential of the global CRISPR and CRISPR-Associated (Cas) Genes market. CRISPR and CRISPR-Associate......

Global Polymerase Chain Reaction (Pcr) Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 120

Market Overview of Global Polymerase Chain Reaction (Pcr) Products market: According to our latest research, the global Polymerase Chain Reaction (Pcr) Products market looks promising in the next 5 years. As of 2022, the global Polymerase Chain Reaction (Pcr) Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents......

Next Generation Sequencing - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 102

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Next Generation Sequencing, with both quanti......

Polymerase Chain Reaction (PCR) Products - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Polymerase Chain Reaction (PCR) Products, wi......

Global Genotyping Market Status and Outlook 2023-2028

Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 128

Genotyping is the technology that detects small genetic differences that can lead to major changes in phenotype, including both physical differences that make us unique and pathological changes underlying disease. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals wh......

Global Pyrosequencing Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101

Pyrosequencing is a method of DNA sequencing that detects light emitted from nucleotide bases.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital f......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs